News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

New Year, new drug for arthritis patients

5 December 2005

New Year, new drug for arthritis patients

People with severe rheumatoid arthritis will have a new subsidised treatment in the New Year following a decision by government drug-funding agency PHARMAC.

The new generation arthritis treatment adalimumab (Humira), one of the TNF alpha inhibitor drugs, will be fully funded for people with severe rheumatoid arthritis from 1 January 2006.

The listing of adalimumab is a significant investment, in the region of $35 million over five years.

PHARMAC Chief Executive Wayne McNee says TNF alpha inhibitors can make a significant difference to the quality of life for people with arthritis.

"For some people with rheumatoid arthritis this can have enormous benefits in enabling them to become more active again," Wayne McNee says.

"We have been working to see at least one of these drugs funded, and this has now been made possible through our agreement with Abbott Laboratories."

PHARMAC estimates that initially a small number of patients will be prescribed adalimumab, but that this group will grow to nearly 1000 people per year after five years. Access to adalimumab will be carefully targeted with access criteria similar to those in Australia.

"Many people already obtain good results from using medicines such as methotrexate or leflunomide, which attack the underlying causes of rheumatoid arthritis," Wayne McNee says. "However, for a small number of patients these medicines aren't sufficient so a TNF alpha inhibitor can make a real difference."

PHARMAC already subsidises one TNF alpha inhibitor, etanercept, for juvenile rheumatoid arthritis. Etanercept will continue to be available to those patients.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Gordon Campbell: Best New Music Of 2017

Any ‘best of list’ has to be an exercise in wishful thinking, given the splintering of everyone’s listening habits... But maybe… it could be time for the re-discovery of the lost art of listening to an entire album, all the way through. Just putting that idea out there. More>>

Scoop Review of Books: Ten x Ten - One Hundred of Te Papa's Best-Loved Art Works

An idiosyncratic selection by ten art curators, each of whom have chosen ten of their favourite works. Handsomely illustrated, their choices are accompanied by full-page colour prints and brief descriptions of the work, explaining in straightforward and approachable language why it is of historical, cultural, or personal significance. More>>

Scoop Review of Books: Portacom City - Reporting On Canterbury Earthquakes

In Portacom City Paul Gorman describes his own deeply personal story of working as a journalist during the quakes, while also speaking more broadly about the challenges that confront reporters at times of crisis. More>>

Scoop Review of Books: Christopher Pugsley’s The Camera in the Crowd - Filming in New Zealand Peace and War 1895-1920

Pugsley brings to life 25 exhilarating years of film making and picture screening in a sumptuously illustrated hardback published by Oratia that tells the story through surviving footage unearthed from the national film archives. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland